Dr. Brett Davis serves as Co-Founder and Chief Executive Officer of Rebel Medicine, where he spearheads initiatives to develop groundbreaking drug delivery technologies aimed at unleashing therapeutic potential of new and existing drugs. In this role, Dr. Davis capitalizes on his extensive research and development background and an innate business acumen to pioneer transformative therapeutic solutions that address significant unmet clinical needs. His strategic vision positions Rebel Medicine at the forefront of next-generation drug delivery, with the goal of enhancing clinical outcomes for patients. Dr. Davis holds more than 6 patents and has contributed extensively to peer-reviewed publications in the field of drug delivery. He holds a PhD in Biomedical Engineering from the University of Utah where his research focused on the design of controlled-release technologies for targeted and extended drug delivery.